On Monday, October 7, 2013, Mark Thompson, President and CEO of The New York Times Company will speak at a press conference to announce the grand re-opening of the Hepatitis B Foundation’s research institute as the “Baruch S. Blumberg Institute.” The new name is to honor the scientific legacy of Foundation Co-Founder Dr. Baruch S. Blumberg, who won the Nobel Prize for his discovery of the hepatitis B virus in 1976.
The press conference will be held at the Pennsylvania Biotechnology Center Building in Doylestown, Pennsylvania, which was created by the Hepatitis B Foundation to accelerate its research mission. Dr. Timothy Block, President of the Foundation and Pennsylvania Biotechnology Center, Mrs. Jean Blumberg, widow of Nobel Prize winner Dr. Baruch Blumberg, and other dignitaries will take part in the ceremonies. Join us for the grand re-opening and refreshments at the conclusion of the ceremony.
The press conference will be held at the Pennsylvania Biotechnology Center Building in Doylestown, Pennsylvania, which was created by the Hepatitis B Foundation to accelerate its research mission. Dr. Timothy Block, President of the Foundation and Pennsylvania Biotechnology Center, Mrs. Jean Blumberg, widow of Nobel Prize winner Dr. Baruch Blumberg, and other dignitaries will take part in the ceremonies. Join us for the grand re-opening and refreshments at the conclusion of the ceremony.
The Hepatitis B Foundation’s research institute – to be renamed the “Baruch S. Blumberg Institute” – has the largest concentration of nonprofit scientists working on hepatitis B and liver cancer in the U.S. and is at the forefront of drug discovery and early detection biomarkers for these two deadly diseases.
Hepatitis B is the most common serious liver infection and the primary cause of liver cancer worldwide. Two billion people have been infected with the hepatitis B virus (one out of three) and 400 million are chronically infected. Each year, 1 million people die prematurely from hepatitis B-related liver disease and liver cancer. In the U.S., an estimated 2 million Americans (or one in 20) are chronically infected with hepatitis B.
About the Baruch S. Blumberg Institute: The Baruch S. Blumberg Institute, formerly the Institute for Hepatitis and Virus Research, is an independent nonprofit research institute established in 2003 by the Hepatitis B Foundation to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus.
About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to www.hepb.org, read the blog at http://wp.hepb.org, follow the Foundation on Twitter @HepBFoundation and Facebook at www.facebook.com/hepbfoundation or call (215) 489-4900.
Members of the media can register for this event by clicking on this link: Grand Re-Opening.
